| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
17,019 |
15,048 |
$1.44M |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
1,472 |
1,439 |
$162K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,715 |
2,423 |
$158K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,183 |
1,137 |
$116K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,296 |
1,229 |
$113K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
660 |
605 |
$84K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
4,371 |
4,040 |
$79K |
| 99215 |
Prolong outpt/office vis |
431 |
412 |
$44K |
| 90674 |
|
1,996 |
1,916 |
$43K |
| 96127 |
|
2,600 |
2,413 |
$37K |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
1,267 |
1,164 |
$35K |
| 99406 |
|
2,089 |
1,887 |
$20K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
1,740 |
1,645 |
$19K |
| 91322 |
|
140 |
133 |
$14K |
| 90715 |
|
359 |
349 |
$14K |
| 0013A |
|
265 |
259 |
$10K |
| 90837 |
Psychotherapy, 53 minutes with patient |
179 |
92 |
$10K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,150 |
1,114 |
$9K |
| 0134A |
|
156 |
150 |
$8K |
| 90661 |
|
305 |
276 |
$8K |
| 0011A |
|
189 |
182 |
$7K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
471 |
417 |
$6K |
| 0012A |
|
157 |
155 |
$6K |
| 90480 |
|
148 |
141 |
$6K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
287 |
273 |
$6K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
56 |
48 |
$5K |
| 90791 |
Psychiatric diagnostic evaluation |
29 |
29 |
$5K |
| 36415 |
Collection of venous blood by venipuncture |
1,728 |
1,645 |
$4K |
| 90651 |
|
60 |
60 |
$4K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
76 |
72 |
$3K |
| 0064A |
|
82 |
82 |
$3K |
| 99000 |
|
2,825 |
2,610 |
$3K |
| 82962 |
|
1,043 |
1,013 |
$2K |
| 81002 |
|
878 |
819 |
$2K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
66 |
58 |
$2K |
| 90677 |
|
13 |
13 |
$2K |
| 90756 |
|
99 |
97 |
$2K |
| 85014 |
|
741 |
660 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
114 |
101 |
$1K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
69 |
67 |
$1K |
| 93000 |
|
70 |
64 |
$1K |
| 81025 |
|
146 |
134 |
$1K |
| 87430 |
|
67 |
63 |
$969.02 |
| H0049 |
Alcohol and/or drug screening |
93 |
91 |
$922.12 |
| 36416 |
|
1,648 |
1,503 |
$873.78 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
41 |
41 |
$619.20 |
| 82947 |
|
136 |
134 |
$581.09 |
| 90653 |
|
30 |
30 |
$333.96 |
| 69210 |
|
15 |
12 |
$314.44 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
189 |
162 |
$261.95 |
| 90694 |
|
57 |
50 |
$248.88 |
| 81003 |
|
96 |
92 |
$239.84 |
| 85018 |
|
75 |
74 |
$229.65 |
| 87400 |
|
19 |
17 |
$218.94 |
| 90658 |
|
13 |
12 |
$152.08 |
| 90686 |
|
97 |
78 |
$110.52 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
12 |
12 |
$0.56 |
| 91313 |
|
131 |
126 |
$0.00 |
| 90734 |
|
12 |
12 |
$0.00 |
| 91301 |
|
422 |
393 |
$0.00 |
| 90688 |
|
45 |
43 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
121 |
111 |
$0.00 |
| 91307 |
|
15 |
13 |
$0.00 |
| 3044F |
|
62 |
60 |
$0.00 |
| 90619 |
|
12 |
12 |
$0.00 |